Cite
HARVARD Citation
Dittner‐Moormann, S. et al. (2021). Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatric blood & cancer. 68 (6), p. n/a. [Online].